Related Articles
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma
Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers
The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers.
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi‑institutional study